In such cases, early failure reflects technological immaturity rather than biological irrelevance
Weeks 1-4: 2mg once weekly Weeks 5-8: 4mg once weekly Weeks 9-12: 8mg once weekly Week 13 onward: 12mg once weekly (maintenance) Total escalation time spans 12 weeks, slower than some competitors but necessary given the triple-receptor mechanism
These drugs are primarily approved for treating type 2 diabetes, so coverage is usually only available if a patient with PCOS also has type 2 diabetes or obesity as a related condition
Early prototypes that embed semaglutide or other incretins in such lipid shells are showing concurrent -cell-targeted contrast and receptor-mediated glucose lowering in diabetic mice, underscoring the therapeutic synergy achievable when magnetic cores are cloaked in a biologically familiar membrane milieu [152]
Urva S, OFarrell L, Du Y, Loh MT, Hemmingway A, Qu H, et al